Prognostic and Clinicopathologic Associations of Oncogenic <i>BRAF</i> in Metastatic Melanoma
Article 2011 en
Authors
GL
Georgina V. Long
AM
Alexander M. Menzies
AN
Adnan Nagrial
Abstract
1 min read
V600K mutations comprised 20% of BRAF mutations. Characteristics of the antecedent primary melanoma and age at diagnosis differed in BRAF-mutant and BRAF wild-type patients. The presence of mutant BRAF had no impact on the disease-free interval from diagnosis of first-ever melanoma to first distant metastasis; however, it may have impacted survival thereafter.
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Alexander M. Menzies, Lauren E. Haydu, Lydia Visintin, Matteo S. Carlino, Julie R. Howle, John F. Thompson, Richard F. Kefford, Richard A Scolyer, Georgina V. Long
Georgina V. Long, Alexander M. Menzies, Adnan Nagrial, Lauren E. Haydu, Anne Hamilton, Graham J. Mann, Michael Hughes, John F. Thompson, Richard A Scolyer, Richard Kefford
Alexander M. Menzies, Lydia Visintin, Mark D. Chatfield, Matteo S. Carlino, Julie R. Howle, Richard A Scolyer, John F. Thompson, Richard Kefford, Georgina V. Long
Discussion(0)
No comments yet. Be the first to comment.